Celso Arrais-Rodrigues

5PUBLICATIONS
46CO-AUTHORS
HaematologyMedical infection agents (incl. prions)AutoimmunityCardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 24, 2026
Patients with myelodysplastic/myeloproliferative neoplasms have higher rates of relapse following allogeneic hematopoietic cell transplantation compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis.

|Jul 30, 2025
Pentraxin 3 as a Potential Biomarker of Invasive Fusariosis in Onco-Haematological Patients.

Larissa Simão Gandolpho, Elaine Cristina Francisco, Giovanni Luis Breda

|Jun 26, 2025
Outcomes After Allogeneic Hematopoietic Cell Transplantation in Adults With Myelodysplastic Syndrome With 65 Years or Older Compared to Youngers. A Retrospective Analysis of the Latin America Registry.

Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Vaneuza Araújo Moreira Funke

|Feb 21, 2025
COVID-19 prior to hematopoietic stem cell transplantation increases the risk of acute graft-versus-host disease but does not affect overall mortality.

Bruno Azevedo Randi, Hermes Ryoiti Higashino, Vinícius Ponzio

|Dec 18, 2024
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates.

Ana Rita da Fonseca, Caio Cesar Justino, Vinicius Campos de Molla

Pageof 1

Frequent Collaborators

2 joint publications

Fernando Barroso Duarte

2 joint publications

Yhasmine Delles Oliveira Garcia

2 joint publications

Vaneuza Araújo Moreira Funke

2 joint publications

Maria Claudia Rodrigues Moreira